- Case Report
- Open access
- Published:
Intestinal Behçet's and suspected intestinal Behçet’s disease: a report of four surgical cases
Surgical Case Reports volume 10, Article number: 3 (2024)
Abstract
Background
Intestinal Behçet's disease (BD) is often associated with ulceration that requires surgery, including perforation and abscess formation. However, no consensus has been reached on the optimal extent of resection or treatment strategy. This study reviewed four cases of intestinal or suspected intestinal BD.
Case presentations
In Case 1, a 74-year-old woman diagnosed with BD 2 years earlier was treated with anti-tumor necrosis factor α antibody (Infliximab) and steroids. She had oral and pubic ulcers. After close investigation of abdominal pain, perforation of the gastrointestinal tract was suspected and surgery was performed. Multiple perforating ulcers and abscesses were found in the distal ileum, and the small intestine was resected. Postoperatively, the patient was treated with an increased steroid dose and symptoms have remained stable. Case 2 involved a 69-year-old woman with oral and pubic ulcers, ocular ulcer, and skin lesions. She experienced sudden onset of abdominal pain during treatment for lymphoma. She showed multiple perforating ulcers throughout the ileum and underwent resection of the small intestine and ileostomy. Upper abdominal pain appeared during postoperative treatment for high-output syndrome. The patient underwent omentoplasty after perforation of the upper gastrointestinal tract was diagnosed. Postoperatively, anti-interleukin-1 beta antibodies (canakinumab) was administered to control the disease. Case 3 involved an 81-year-old, previously healthy woman. She presented to her previous physician with complaints of pubic ulcer, hemorrhage and abdominal pain. Colonoscopy showed multiple ulcers throughout the entire colon. Steroid therapy was started, but bleeding proved difficult to control and total proctocolectomy was performed. Histopathology revealed multiple perforating ulcers and BD was diagnosed. Postoperatively, the patient remains under steroid control. Case 4 involved a 43-year-old man with abdominal pain who showed abscess formation in the ileocecal region. After excision of the ileocecal area, multiple ulcers were diagnosed. Two years later, abdominal pain recurred and free air was found in the abdomen on close imaging. Emergency anastomotic resection was performed due to ulceration and perforation of the anastomosis.
Conclusions
Intestinal BD may flare up after surgical treatment and require multiple surgeries. Introducing pharmacotherapy as soon as possible after surgical treatment is important to control the disease.
Background
Behçet's disease (BD) is a chronic inflammatory immune-mediated disease characterized by recurrent oral and genital ulcers and ocular and dermatological pathologies [1,2,3]. The prevalence of BD ranges from 0.27 to 5.2 per 100,000 in North America and Scandinavian countries to about 10 per 100,000 in Asia [4]. Patients with BD features who present with ulceration mainly in the ileocecal region and can be differentiated from other etiologies (such as Crohn's disease, intestinal tuberculosis, and drug-induced enterocolitis) are considered to have intestinal BD [5]. The basic treatment for intestinal BD is pharmacotherapy with steroids and anti-tumor necrosis factor α (TNFα) antibodies, but intestinal perforation, bleeding, or stricture often necessitate surgical treatment [6]. Surgery for intestinal BD is associated with a high risk of reoperation (30–44%), but no clear consensus has been reached regarding the appropriate extent of resection or optimal treatment strategy [7,8,9]. Here, we review four cases of intestinal or suspected intestinal BD at our hospital and discuss the effects of drug therapy and surgery on prognosis.
Case presentations
Tables 1 and 2 summarize the 6 surgeries conducted for the 4 cases. Patients ranged in age from 43 to 74 years, and 3 patients were female. The underlying disease was myelodysplastic syndrome (MDS) in 1 case, malignant lymphoma in 1 case, and asthma in 1 case, with no underlying pathology in the remaining case. One patient had complete BD with all 4 main signs (oral ulcer, genital ulcer, ocular ulcer, and skin lesion) and 3 cases had incomplete BD. Three of the 6 surgeries were performed for perforation, 2 for abscess formation, and 1 for bleeding. Postoperative complications (high-output syndrome in 1 case; surgical site infection in 1 case) were observed in two patients. The details of each case are described below.
Case 1 involved a 74-year-old woman who had been diagnosed with BD and MDS 2 years earlier and was receiving treatment with anti-TNFα antibody (Infliximab) and steroids. She presented with oral and pubic ulcers. She had experienced sudden abdominal pain and fever around 38 °C, and computed tomography (CT) of the abdomen revealed free air (Fig. 1). Emergency surgery was performed based on a diagnosis of gastrointestinal perforation. Multiple perforating ulcers and abscesses were found in the distal ileum. In addition, partial resection of the small intestine was performed (Fig. 2). The length of bowel resection was 85 cm. Histopathologically, the multiple ulcers were consistent with intestinal BD ulceration, as most ulcers reached deep to the subserosal layer (Fig. 3). The patient continued to receive anti-TNFα antibody (Infliximab) postoperatively and steroid dosage was increased. As of 2 years postoperatively, the intestinal BD remained under control.
Case 2 involved a 69-year-old woman under medical treatment for malignant lymphoma. She had oral, pubic, ocular and skin ulcers. After sudden onset of abdominal pain, CT of the abdomen revealed free air. Emergency surgery was performed under a diagnosis of perforation of the gastrointestinal tract. Multiple perforating ulcers were observed in the ileum, so resection of the small intestine and construction of an ileostomy were performed. The extent of resection was 100 cm considering the perforation site and the condition of the intestinal wall. Finally, the distance to the ileostomy site from the beginning of the jejunum was 120 cm. Histopathological findings showed that there was a nonspecific ulcer seen in Behçet's disease, not malignant lymphoma. After surgery, the patient suffered from high-output syndrome and could not administer the steroid. An upper abdominal pain suddenly appeared 48 days after surgery. Abdominal CT showed free air mainly in the upper abdomen, and the patient underwent reoperation based on the diagnosis of perforation of the upper gastrointestinal tract. Since a perforation was found in the duodenal bulb, omentoplasty was performed. It was determined that the cause was due to intestinal BD, as the perforation was caused by the failure of appropriate drug treatment and BD was uncontrollable, including worsening ocular symptoms and skin ulcers. Thereafter, the patient was treated with steroids and anti-IL-1β antibody (canakinumab). The ileostoma was closed 1.5 years after the initial surgery. As of 2 years postoperatively, the patient has shown no recurrence of intestinal BD.
Case 3 was an 81-year-old woman with no previous medical history. Six months earlier, she had developed lower abdominal pain and watery stools, and colonoscopy revealed multiple ulcers throughout the entire colon (Fig. 4). Since she also had a vulvar ulcer, we suspected intestinal BD and started steroids at 30 mg/day, but the hemostasis could not be achieved. Follow-up endoscopy showed that multiple ulcers remained and the patient was judged as difficult to treat medically, so laparoscopic total proctocolectomy plus ileostomy was performed. The length of bowel resection was 130 cm. Histopathology showed multiple perforating ulcers. After surgery, the patient continued to receive steroids and the disease remained well-controlled. As of 4 years postoperatively, no relapses of intestinal BD have been identified.
Case 4 involved a 43-year-old man showing abscess formation in the ileocecal region on CT of the abdomen for close examination of abdominal pain. Emergency ileal resection was performed and pathological examination diagnosed abscess formation due to multiple ulcers. We suspected intestinal BD. Two years later, he revisited our hospital with abdominal pain and underwent anastomotic resection and ileostomy under a diagnosis of retroperitoneal abscess caused by anastomotic ulceration. Thereafter, treatment was initiated with steroids, 5-aminosalicylic acid and colchicine to control the disease. Twenty-six years after disease onset, the ileostomy was closed. No recurrence of intestinal BD has been identified postoperatively.
Discussion
Intestinal BD is recognized as a special form of BD with ulcerative lesions in the intestinal tract. Although the incidence of gastrointestinal involvement in BD patients varies by region, Japan is reported to show a relatively high incidence of around 50%, and clinicians should be aware of the diagnosis, treatment and follow-up of this pathology [6]. Intestinal BD is said to mainly present with deep, punch-like ulcers with well-defined ulcer margins, showing a predilection (60–75%) for the ileal region [9]. All four cases in the present study also presented with ulcers in the vicinity of the ileocecal area, similar to previous reports.
Pathological features of intestinal BD ulcers include the formation of lymphoid follicles and lymphocytic infiltration around the ulcer, but the periumbilical membrane in the non-ulcer area is reportedly normal [10]. In addition, fissuring from the bottom of the ulcer to the intestinal serosa and weak collagen fiber growth are considered to predispose to perforation [10]. Complications of intestinal BD that require surgery include stenosis, abscess formation, fistula, and intestinal perforation. In previous reports, perforation was the most common complication of intestinal BD (3.3–12.7%) [7]. Of the six surgeries included in this study, four (67%) were perforations of the intestine, likely due to deep ulcers.
When surgery is actually deemed necessary, the optimal extent of bowel resection remains controversial. Chou et al. reported that a greater extent of bowel resection with extended surgery is preferable because of the risk of recurrent ulcers with disease progression [11]. On the other hand, a recent report found no relationship between the length of resection and the recurrence rate, and minimal resection has been recommended [7]. Of the four patients in the present study, those with multiple ulcers underwent minimal resection as necessary. As for the patient who had undergone ileal resection 2 years earlier for ileal abscess, although local resection was performed again due to ulcers causing abscess formation at the anastomotic site.
Some reports have suggested that stoma creation is preferable to temporary anastomosis for patients with intestinal BD because of the high risk of anastomotic leak, perforation, or fistula after surgery due to the general condition of patients and the likelihood of intra-abdominal contamination [12, 13]. However, due to the infrequency of intestinal Behçet's, there is a paucity of literature detailing the causes of the high incidence of anastomotic problems in Behçet's disease. Further case series are needed. In addition, when surgery is required in the chronic stage of intestinal BD, the patient is often treated with steroids, which increases the risk of anastomotic leak, so stoma placement should be considered [12, 13]. Among the six surgeries performed in this study, stoma creation was performed in three cases of steroid therapy and peritonitis. Two cases of them, stoma closure could be achieved at a later date. However, the patient in Case 2 developed high-output syndrome of the ileostomy after the initial surgery and required long-term systemic management. This delayed drug therapy for BD, resulting in aggravation of skin ulcers, ocular ulcers, and gastrointestinal ulcers and BD-related duodenal perforation. The choice of surgical technique thus needs to be considered with care to ensure timely initiation of drug therapy in the early postoperative period.
Intestinal BD is associated with a high reoperation rate of 30–44%, often with the appearance of new lesions at or near the anastomosis [7,8,9]. Poorly controlled conditions are risk factors [14]. Obtaining control of the disease status of BD early after surgery is important, requiring various drugs [3].
In Case 1, the patient had intestinal BD complicated with MDS. Eighty-seven percent of BD patients with MDS were reported to have trisomy 8, which was associated with poor response to treatment and poor prognosis [15, 16]. Case 1 also had trisomy 8 and developed intestinal BD exacerbation despite ongoing anti-TNFα antibody (Infliximab) and steroid therapy. Adequate drug control was considered important for the refractory patient.
Conclusions
In this study, we have described four cases of intestinal or suspected intestinal BD that underwent surgical procedures. Appropriate surgical intervention and postoperative pharmacotherapy to control the disease were important in each case.
Availability of data and materials
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Abbreviations
- BD:
-
Behçet’s disease
- TNFα:
-
Tumor necrosis factor-a
- MDS:
-
Myelodysplastic syndrome
References
Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med. 1999;341(17):1284–91.
Saleh Z, Arayssi T. Update on the therapy of Behçet disease. Ther Adv Chronic Dis. 2014;5(3):112–34.
Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T. Behçet’s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol. 2006;25(3):364–7.
Mahr A, Maldini C. Epidemiology of Behçet’s disease. Rev Med Interne. 2014;35(2):81–9.
Hisamatsu T, Ueno F, Matsumoto T, Kobayashi K, Koganei K, Kunisaki R, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies. J Gastroenterol. 2014;49(1):156–62.
Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behcet’s disease: a review. World J Gastroenterol. 2015;21(13):3801–12.
Jung YS, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17(7):1594–602.
Naganuma M, Iwao Y, Inoue N, Hisamatsu T, Imaeda H, Ishii H, et al. Analysis of clinical course and long-term prognosis of surgical and nonsurgical patients with intestinal Behçet’s disease. Am J Gastroenterol. 2000;95(10):2848–51.
Kasahara Y, Tanaka S, Nishino M, Umemura H, Shiraha S, Kuyama T. Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature. Dis Colon Rectum. 1981;24(2):103–6.
Nguyen A, Upadhyay S, Javaid MA, Qureshi AM, Haseeb S, Javed N, et al. Behcet’s disease: an in-depth review about pathogenesis, gastrointestinal manifestations, and management. Inflamm Intestinal Dis. 2021;6(4):175–85.
Chou SJ, Chen VT, Jan HC, Lou MA, Liu YM. Intestinal perforations in Behçet’s disease. J Gastrointest Surg. 2007;11(4):508–14.
Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol. 2000;30(2):144–54.
Moon CM, Cheon JH, Shin JK, Jeon SM, Bok HJ, Lee JH, et al. Prediction of free bowel perforation in patients with intestinal Behçet’s disease using clinical and colonoscopic findings. Dig Dis Sci. 2010;55(10):2904–11.
Han SJ, Kang EA, Park J, Park SJ, Park JJ, Kim TI, et al. Risk factors for surgery in patients with intestinal Behcet’s disease during anti-tumor necrosis factor-alpha therapy. Yonsei Med J. 2023;64(2):111–6.
Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, et al. The association of Behçet’s disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol. 2006;24(5):115–9.
Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndrome as a risk factor for intestinal ulcer and thrombosis-Bechet’s syndrome. Leul Lymphoma. 2001;42(1):115–21.
Acknowledgements
The authors would like to thank FORTE Science Communications (https://www.fortescience.com/) for English language editing.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
RO and TT conceptualized the study. TN, YT, KO, TS, SH, and KN collaborated in providing patient care. TS and TN provided input on the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was performed in line with the principles of the 1964 Declaration of Helsinki and its later amendments. Approval was granted by the Clinical Research Review Boards.
Consent for publication
Written, informed consent was obtained from the patients for publication of this case series.
Competing interests
The authors declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ono, R., Tominaga, T., Nonaka, T. et al. Intestinal Behçet's and suspected intestinal Behçet’s disease: a report of four surgical cases. surg case rep 10, 3 (2024). https://doi.org/10.1186/s40792-023-01798-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40792-023-01798-2